cgoncology.comHealthcare / BioTech & PharmaFounded: 2010Funding to Date: $307.89MM
CG Oncology is a developer of genitally engineered oncolytic immunotherapy treatments for individuals with advanced cancer.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/02/2023 | Series F | $105.02MM | $xx.xx | $615.24MM | Foresite Capital, TCGX, Avidity Partners, BVF Partners, Janus Henderson Investors, Acorn Bioventures, Ally Bridge Group, Decheng Capital, Longitude Capital, Malin Corporatoin, RA Capital Management | |
Price per Share
$xx.xx
Shares Outstanding
81,587,937
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Foresite Capital, TCGX, Avidity Partners, BVF Partners, Janus Henderson Investors, Acorn Bioventures, Ally Bridge Group, Decheng Capital, Longitude Capital, Malin Corporatoin, RA Capital Management
|
||||||
09/30/2022 | Series E | $120MM | $xx.xx | $405.38MM | Decheng Capital, Palm Drive Capital | |
Price per Share
$xx.xx
Shares Outstanding
112,422,700
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Decheng Capital, Palm Drive Capital
|
||||||
12/10/2020 | Series D | $47.3MM | $xx.xx | $212.97MM | Kissei Pharmaceutical, ORI Healthcare Fund, Camford Capital, Perservance Capital Management | |
Price per Share
$xx.xx
Shares Outstanding
53,271,754
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Kissei Pharmaceutical, ORI Healthcare Fund, Camford Capital, Perservance Capital Management
|
||||||
03/18/2019 | Series C | $22MM | $xx.xx | $54.19MM | ORI Healthcare Fund, Perserverance Capital Management | |
Price per Share
$xx.xx
Shares Outstanding
73,598,283
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
ORI Healthcare Fund, Perserverance Capital Management
|
||||||
08/05/2015 | Series B | $10MM | $xx.xx | $31.64MM | Ally Bridge Group, WI Harper Group, Whitesun Healthcare Ventures, Song Hong Fang | |
Price per Share
$xx.xx
Shares Outstanding
11,973,000
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Ally Bridge Group, WI Harper Group, Whitesun Healthcare Ventures, Song Hong Fang
|
||||||
07/28/2014 | Series A-1 | $3.57MM | $xx.xx | $11.9MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
5,075,000
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
3.0
Key Investors
Undisclosed Investors
|